Hospital
Alameda Health System
Alameda Health System was paid $7.76M by Medicaid between Jan 2018 and Dec 2024, across 170 billing codes. Its largest line is 99284, emergency room visit (serious) — 21% of everything it billed.
33Billing provider infoALAMEDA HEALTH SYSTEM
SAN LEANDRO, CA 94578
SAN LEANDRO, CA 94578
33aNPI1104267848assigned 07/10/2013
33bProvider typeGeneral Acute Care Hospital
28Total paid$7.76M
24GClaims215,927
24DCodes billed170
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#201 of 410
Median peer was paid$6.90M
This provider vs. median1.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 82,540 | $2.99M | |
| 2019 | 55,205 | $1.98M | |
| 2023 | 12 | $647.28 | |
| 2024incomplete | 78,170 | $2.79M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 21% | 28,123 | 24,468 | $1.62M |
| J3490 | Unclassified drugs | 8.9% | 7,363 | 6,069 | $694K |
| 99070 | 6.2% | 17,595 | 7,896 | $483K | |
| 70450 | Computed tomography, head or brain; without contrast material | 4.8% | 1,532 | 1,475 | $375K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.5% | 4,135 | 3,876 | $348K |
| 0450 | Emergency room services | 4.2% | 5,596 | 4,863 | $325K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.2% | 1,161 | 1,120 | $324K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 4.0% | 7,597 | 6,952 | $307K |
| 99221 | 3.8% | 365 | 139 | $298K | |
| 99218 | 3.0% | 535 | 274 | $233K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.3% | 2,915 | 2,701 | $177K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1.9% | 2,041 | 1,866 | $146K |
158 more codes
| 96361 | Intravenous infusion, hydration; each additional hour | 1.9% | 2,833 | $145K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.8% | 4,070 | $139K |
| 80053 | Comprehensive metabolic panel | 1.6% | 13,337 | $126K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.3% | 389 | $103K |
| Z7502 | 1.2% | 2,632 | $96K | |
| T1999 | Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" | 1.2% | 2,618 | $93K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.1% | 807 | $86K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.1% | 715 | $85K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.1% | 14,466 | $83K |
| 71046 | Radiologic examination, chest; 2 views | 1.0% | 3,014 | $81K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 796 | $73K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 471 | $66K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 852 | $56K |
| 71045 | Radiologic examination, chest; single view | <1% | 3,378 | $48K |
| 83880 | <1% | 2,045 | $44K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,661 | $44K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,663 | $44K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,069 | $42K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 471 | $39K |
| 83690 | <1% | 7,437 | $39K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 497 | $37K |
| 84484 | <1% | 4,666 | $35K | |
| 76830 | Ultrasound, transvaginal | <1% | 422 | $31K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 88 | $29K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 75 | $29K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,227 | $29K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 102 | $27K |
| 70498 | <1% | 69 | $26K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 1,806 | $26K |
| 86703 | <1% | 2,402 | $24K | |
| 80306 | <1% | 1,516 | $23K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,040 | $23K |
| 93308 | <1% | 82 | $21K | |
| 73030 | <1% | 559 | $20K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,499 | $19K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 524 | $19K |
| 70496 | <1% | 45 | $17K | |
| 73630 | <1% | 569 | $17K | |
| 76801 | <1% | 265 | $17K | |
| 73562 | <1% | 499 | $15K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 153 | $14K |
| 73610 | <1% | 382 | $14K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,135 | $13K |
| 71250 | <1% | 40 | $13K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 71 | $13K |
| 81001 | <1% | 4,851 | $12K | |
| 81025 | <1% | 4,064 | $12K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,385 | $12K |
| 73130 | <1% | 335 | $11K | |
| 84702 | <1% | 1,060 | $10K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,446 | $10K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,046 | $9K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 353 | $9K |
| 83605 | <1% | 1,011 | $9K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,516 | $9K |
| 87040 | <1% | 585 | $9K | |
| 99199 | Unlisted special service, procedure or report | <1% | 144 | $9K |
| 90715 | <1% | 219 | $9K | |
| 81003 | <1% | 4,693 | $8K | |
| 70486 | <1% | 28 | $7K | |
| 99283 | Emergency room visit (moderate) | <1% | 186 | $7K |
| 87088 | <1% | 1,319 | $7K | |
| 93971 | <1% | 36 | $7K | |
| 94664 | <1% | 401 | $7K | |
| 84703 | <1% | 1,647 | $7K | |
| 82553 | <1% | 676 | $7K | |
| 72100 | <1% | 185 | $7K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 675 | $6K |
| 83735 | <1% | 1,271 | $6K | |
| 86803 | <1% | 510 | $6K | |
| 87081 | <1% | 882 | $5K | |
| 87634 | <1% | 84 | $5K | |
| J1815 | Injection, insulin, per 5 units | <1% | 55 | $5K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 152 | $5K |
| Z7610 | <1% | 388 | $5K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 381 | $5K |
| 87186 | <1% | 829 | $4K | |
| 73560 | <1% | 169 | $4K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 13 | $4K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 713 | $4K |
| 85610 | <1% | 1,339 | $4K | |
| 82550 | <1% | 754 | $4K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 623 | $3K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 151 | $3K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 26 | $3K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 477 | $3K |
| 87210 | <1% | 794 | $3K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 496 | $3K |
| 94060 | <1% | 27 | $3K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 453 | $3K |
| 82803 | <1% | 132 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 312 | $2K |
| 87077 | <1% | 228 | $2K | |
| 71271 | <1% | 16 | $2K | |
| 77066 | Tomosynthesis, mammo | <1% | 12 | $2K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 208 | $2K |
| 85379 | <1% | 293 | $2K | |
| 76604 | <1% | 25 | $2K | |
| 93226 | <1% | 20 | $2K | |
| 82962 | <1% | 851 | $2K | |
| J3486 | Injection, ziprasidone mesylate, 10 mg | <1% | 83 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 251 | $2K |
| 85027 | <1% | 303 | $2K | |
| 93225 | <1% | 20 | $1K | |
| 76775 | <1% | 13 | $1K | |
| 80143 | <1% | 123 | $1K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 29 | $1K |
| 80179 | <1% | 118 | $1K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 13 | $1K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 64 | $1K |
| 87341 | <1% | 185 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 223 | $1K |
| 71010 | <1% | 52 | $1K | |
| 76642 | <1% | 14 | $1K | |
| 94729 | <1% | 14 | $977.52 | |
| 85730 | <1% | 227 | $913.14 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 186 | $896.54 |
| 94726 | <1% | 13 | $893.97 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 469 | $888.05 |
| 86780 | <1% | 78 | $877.80 | |
| 87340 | <1% | 100 | $875.52 | |
| 0250 | <1% | 75 | $827.18 | |
| 87490 | <1% | 33 | $689.09 | |
| 73590 | <1% | 17 | $665.10 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 119 | $665.05 |
| 90656 | <1% | 16 | $664.96 | |
| 71020 | <1% | 18 | $624.01 | |
| 73502 | <1% | 28 | $620.46 | |
| 73110 | <1% | 14 | $597.14 | |
| 87590 | <1% | 33 | $575.09 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 16 | $518.08 |
| 82140 | <1% | 44 | $474.22 | |
| 82009 | <1% | 130 | $467.98 | |
| 94760 | <1% | 37 | $448.71 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 45 | $416.11 |
| 86140 | <1% | 74 | $331.20 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 31 | $292.56 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 13 | $179.03 |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 12 | $172.63 |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 13 | $160.23 |
| 87400 | <1% | 13 | $159.82 | |
| 80061 | Lipid panel | <1% | 14 | $150.02 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 39 | $147.21 |
| 81015 | <1% | 73 | $144.12 | |
| 85007 | <1% | 47 | $142.32 | |
| 86901 | <1% | 55 | $137.76 | |
| 86900 | <1% | 55 | $133.28 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 13 | $116.73 |
| 87147 | <1% | 14 | $105.27 | |
| 88304 | <1% | 13 | $98.54 | |
| 86850 | <1% | 42 | $96.20 | |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 14 | $82.18 |
| 86885 | <1% | 15 | $66.88 | |
| 82010 | <1% | 15 | $21.45 | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 69 | $7.79 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 18 | $6.07 |
| 0250R | 0% | 98 | $0.00 | |
| 99285 | Emergency room visit (most serious) | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJENSEN, BERNADETTE (VP OF REVENUE CYCLE)
| Provider | Location | Paid |
|---|---|---|
| Alameda Health System | Hayward, CA | $32.74M |
| Alameda Health System | San Leandro, CA | $30.62M |
| Alameda Health System | Newark, CA | $26.92M |
| Alameda Health System | Oakland, CA | $877K |
| Alameda Health System | Newark, CA | $458K |
| Alameda Health System | Oakland, CA | $89K |
| Alameda Health System | Alameda, CA | $21K |
| Alameda Health System | Newark, CA | $2K |
| Alameda Health System | San Leandro, CA | $1K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.